Understanding TB and HIV co-infections

Characteristics and Outcomes of TB and HIV Co-infections

Observational Assiut University · NCT06531772

This study looks at how having both HIV and tuberculosis affects people's health and healthcare in developing countries to help improve treatment and prevention.

Quick facts

Study typeObservational
Enrollment100 (estimated)
SexAll
SponsorAssiut University Academic / other
Locations1 site (Asyut)
Trial IDNCT06531772 on ClinicalTrials.gov

What this trial studies

This observational study focuses on individuals living with HIV who are also diagnosed with tuberculosis (TB), a common opportunistic infection in this population. It aims to characterize the outcomes of TB-HIV co-infections, particularly in developing countries where both diseases are prevalent. The study will analyze the impact of these co-infections on health outcomes and the burden they place on healthcare systems. By examining the relationship between HIV and TB, the research seeks to inform better prevention and treatment strategies.

Who should consider this trial

Good fit: Ideal candidates for this study are individuals who have a laboratory diagnosis of TB-HIV co-infection.

Not a fit: Patients who refuse to participate in the study will not benefit from its findings.

Why it matters

Potential benefit: If successful, this study could lead to improved management and treatment strategies for patients suffering from both HIV and TB.

How similar studies have performed: Previous studies have highlighted the challenges of TB-HIV co-infections, indicating that this area of research is critical but still requires further exploration.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Laboratory diagnosis of TB-HIV co-infection

Exclusion Criteria:

* Patients refusing to participate in the study

Where this trial is running

Asyut

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Human Immunodeficiency VirusMycobacterium Tuberculosis
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.